ALARIS Medical Inc. approved for NASDAQ Stock Market listing; plans to begin trading under "ALRS" in June.SAN DIEGO--(BUSINESS WIRE)--May 29, 1997--ALARIS Medical Inc. (presently ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :AMA (Automatic Message Accounting) The recording and reporting of telephone calls within a telephone system. It includes the calling and called parties and start and stop times of the call. ) Thursday announced it has been approved for listing on the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on National Market. The company expects to begin listing in June under the symbol "ALRS ALRS Admiralty List of Radio Signals ALRS Alerting Service (aviation) ALRS Apache Leap Research Site ALRS Alternate Launch & Recovery Surface ALRS Automated Logistics Retrieval System ALRS Automatic Line Router Switch ." President and Chief Executive Officer William J. Mercer said, "As a global leader in intravenous infusion systems and periodic patient monitoring products, we think the NASDAQ market maker system will lead to greater visibility and shareholder value. "Since the November 1996 merger and integration of IMED IMED International Medical Education Directory Corp. and IVAC IVAC Islington Voluntary Action Council (England, UK) IVAC Insert Valid Access Card (satellite TV hacking) IVAC International Video & Audio Convention IVAC Idle Air Control Valve Medical Systems Inc., we have emerged a stronger, more competitive company, eager to shed our old identity and gain recognition as a major global player in advanced medical instruments and devices." Mercer noted that the move is consistent with ALARIS Medical's desire to be perceived as a high-tech, high-growth stock. "We have elected to pursue what we think is a more compatible marketplace on the NASDAQ NMS See NetWare Management System. ," he said. "This strategic move supports our intent to continue to build upon our strong position in medical technology around the patient bedside. We believe this is an exciting place to be listed at this stage of transition for our company." Statements in this news release which are not historical facts, including statements about expectations regarding financial performances, are forward-looking statements that involve risk and uncertainties. Risk factors, including without limitation changes in the market and competition, are detailed in the Securities and Exchange Commission filings of Advanced Medical Inc. and IVAC Medical Systems Inc., particularly the Advanced Medical form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. filing for the year ended Dec. 31, 1996. Previously known as Advanced Medical Inc., the company announced a name change to ALARIS Medical Inc. in May 1997. Its operating company, ALARIS Medical Systems Inc., is known for its IMED and IVAC brand names of intravenous infusion therapy systems. The company's principal line of business is the design, manufacture and marketing of intravenous infusion therapy products, periodic patient monitoring instruments and related disposables. ALARIS Medical's products are distributed to more than 120 countries worldwide. In addition to its San Diego world headquarters and manufacturing facility, the company also operates manufacturing facilities in Creedmoor, N.C.; Basingstok, Hampshire, U.K.; and Tijuana, Mexico. CONTACT: ALARIS Medical Inc., San Diego Barbara Burkett, 619/458-7038 or Financial Relations Board, Los Angeles 310/442-0599 Stacy Roughan (general information) Moira Conlon/Michaelle Burstin (investor/analyst contact) Steven Seiler (media contact) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion